|
US4777964A
(en)
|
1986-01-02 |
1988-10-18 |
David Briggs |
System for obtaining blood samples and submitting for testing of aids
|
|
US5223440A
(en)
|
1987-11-17 |
1993-06-29 |
Adeza Biomedical Corporation |
Ex vivo product of conception test to determine abortion
|
|
US5096830A
(en)
|
1987-11-17 |
1992-03-17 |
Adeza Biomedical Corporation |
Preterm labor and membrane rupture test
|
|
US4919889A
(en)
|
1988-09-15 |
1990-04-24 |
Aspen Diagnostics Corporation |
Sample collection and transport fluid composition
|
|
US5281522A
(en)
|
1988-09-15 |
1994-01-25 |
Adeza Biomedical Corporation |
Reagents and kits for determination of fetal fibronectin in a vaginal sample
|
|
WO1993009432A1
(en)
|
1991-11-04 |
1993-05-13 |
Adeza Biomedical Corporation |
Screening method for identifying women at increased risk for imminent delivery
|
|
CA2121680C
(en)
|
1991-11-04 |
2005-03-22 |
Andrew E. Senyei |
Screening method for identifying women at increased risk for preterm delivery
|
|
US5516702A
(en)
|
1991-11-06 |
1996-05-14 |
Adeza Biomedical Corporation |
Screening method for identifying women at increased risk for imminent delivery
|
|
US5898005A
(en)
|
1993-02-24 |
1999-04-27 |
Dade Behring Inc. |
Rapid detection of analytes with receptors immobilized on soluble submicron particles
|
|
ES2132392T3
(es)
|
1993-02-24 |
1999-08-16 |
Dade Behring Inc |
Inmovilizacion de reactivos de ensayo de enlace especifico.
|
|
US5783396A
(en)
|
1993-03-23 |
1998-07-21 |
Voroteliak; Victor |
Method of detecting rupture of the amniotic membranes in pregnant mammals
|
|
US5431171A
(en)
|
1993-06-25 |
1995-07-11 |
The Regents Of The University Of California |
Monitoring fetal characteristics by radiotelemetric transmission
|
|
JP3498960B2
(ja)
|
1993-09-03 |
2004-02-23 |
デイド・ベーリング・マルブルク・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツング |
蛍光酸素チャンネリングイムノアッセイ
|
|
US5650394A
(en)
|
1993-11-04 |
1997-07-22 |
Adeza Biomedical |
Use of urinastatin-like compounds to prevent premature delivery
|
|
US5597700A
(en)
|
1994-04-28 |
1997-01-28 |
California Research, Llc |
Method for detecting free insulin-like growth-factor-binding protein 1 and a test device for detecting the ruptures of fetal membranes using the above method
|
|
US6140099A
(en)
|
1994-05-20 |
2000-10-31 |
The Trustees Of The University Of Pennsylvania |
Method of delaying fetal membrane rupture by inhibiting matrix metalloproteinase-9 activity
|
|
US5641636A
(en)
|
1994-05-20 |
1997-06-24 |
University Of Pennsylvania |
Method of predicting fetal membrane rupture based on matrix metalloproteinase-9 activity
|
|
WO1996023066A2
(en)
|
1995-01-26 |
1996-08-01 |
Merck Frosst Canada Inc. |
Prostaglandin receptor, dp
|
|
CA2235845C
(en)
|
1995-10-31 |
2005-05-17 |
Maruha Corporation |
Prostaglandin d synthase-specific monoclonal antibody
|
|
US6678669B2
(en)
|
1996-02-09 |
2004-01-13 |
Adeza Biomedical Corporation |
Method for selecting medical and biochemical diagnostic tests using neural network-related applications
|
|
US6544193B2
(en)
|
1996-09-04 |
2003-04-08 |
Marcio Marc Abreu |
Noninvasive measurement of chemical substances
|
|
US6120460A
(en)
|
1996-09-04 |
2000-09-19 |
Abreu; Marcio Marc |
Method and apparatus for signal acquisition, processing and transmission for evaluation of bodily functions
|
|
FI963989A7
(fi)
|
1996-10-04 |
1998-04-05 |
Wallac Oy |
Homogeenisiä määritysmenetelmiä, jotka perustuvat luminesenssienergiasiirtoon
|
|
CA2283356C
(en)
|
1997-03-07 |
2009-06-30 |
Mount Sinai Hospital |
Methods to diagnose a required regulation of trophoblast invasion
|
|
US6610480B1
(en)
|
1997-11-10 |
2003-08-26 |
Genentech, Inc. |
Treatment and diagnosis of cardiac hypertrophy
|
|
US6875567B1
(en)
|
1997-11-10 |
2005-04-05 |
Genentech, Inc. |
Method of detecting cardiac hypertrophy through probe hybridization and gene expression analysis
|
|
US20020031513A1
(en)
|
1997-11-24 |
2002-03-14 |
Shamir Leibovitz |
Method and pharmaceutical composition for inhibiting premature rapture of fetal membranes, ripening of uterine cervix and preterm labor in mammals
|
|
US6267722B1
(en)
|
1998-02-03 |
2001-07-31 |
Adeza Biomedical Corporation |
Point of care diagnostic systems
|
|
US6394952B1
(en)
|
1998-02-03 |
2002-05-28 |
Adeza Biomedical Corporation |
Point of care diagnostic systems
|
|
US6506789B2
(en)
|
1998-06-03 |
2003-01-14 |
Shionogi & Co., Ltd. |
Methods for the treatment of itching comprising administering PGD2 receptor antagonist
|
|
US6126597A
(en)
|
1998-07-22 |
2000-10-03 |
Smith; Ramada S. |
System for identifying premature rupture of membrane during pregnancy
|
|
US20010025140A1
(en)
|
1998-07-22 |
2001-09-27 |
Torok Brian A. |
System for identifying premature rupture of membrane during pregnancy
|
|
US6149590A
(en)
|
1998-07-22 |
2000-11-21 |
Smith; Ramada S. |
System for identifying premature rupture of membrane during pregnancy
|
|
US7109044B1
(en)
|
1998-09-04 |
2006-09-19 |
Maruha Corporation |
Method of detection and disease state management for renal diseases
|
|
WO2000025781A1
(en)
|
1998-10-29 |
2000-05-11 |
Board Of Regents, The University Of Texas System |
Use of thiazolidinediones derivatives for preventing uterine contractions in premature labour or lactation
|
|
JP2000249709A
(ja)
|
1999-02-26 |
2000-09-14 |
Maruha Corp |
冠血管インターベンション施行後の再狭窄の予測方法
|
|
US6126616A
(en)
|
1999-06-21 |
2000-10-03 |
Sanyal; Mrinal K. |
Collection of biological products from human accessory reproductive organs by absorbent systems
|
|
US6884593B1
(en)
|
1999-08-23 |
2005-04-26 |
Bml, Inc. |
Method of identifying properties of substance with respect to human prostaglandin D2 receptors
|
|
FR2809182B1
(fr)
|
2000-05-18 |
2003-08-15 |
Univ Rene Descartes |
Detection de l'il-6 pour la prevision des risques d'accouchement premature
|
|
US20010053876A1
(en)
|
2000-06-15 |
2001-12-20 |
Torok Brian A. |
System for identifying premature rupture of membrane during pregnancy
|
|
US6878522B2
(en)
|
2000-07-07 |
2005-04-12 |
Baiyong Li |
Methods for the identification of compounds useful for the treatment of disease states mediated by prostaglandin D2
|
|
CA2417669C
(en)
|
2000-07-21 |
2009-09-15 |
Maruha Corporation |
Methods for differentiating demential diseases
|
|
US6410583B1
(en)
|
2000-07-25 |
2002-06-25 |
Merck Frosst Canada & Co. |
Cyclopentanoindoles, compositions containing such compounds and methods of treatment
|
|
AU2001288410A1
(en)
|
2000-08-28 |
2002-03-13 |
Patrick G. Morand |
Use of blood and plasma donor samples and data in the drug discovery process
|
|
US7217725B2
(en)
|
2000-09-14 |
2007-05-15 |
Allergan, Inc. |
Prostaglandin D2 antagonist
|
|
JP2004511254A
(ja)
|
2000-10-16 |
2004-04-15 |
バイエル アクチェンゲゼルシャフト |
ヒト樹状細胞免疫受容体の調節
|
|
US7635571B2
(en)
|
2000-12-07 |
2009-12-22 |
Siemens Healthcare Diagnostics Products Gmbh |
Amplified signal in binding assays
|
|
AU2002302248B2
(en)
|
2001-05-23 |
2008-03-06 |
Merck Frosst Canada Ltd. |
Dihydropyrrolo[1,2-A]indole and tetrahydropyrido[1,2-A]-indole derivatives as prostaglandin D2 receptor antagonists
|
|
WO2003008978A2
(en)
|
2001-07-18 |
2003-01-30 |
Merck Frosst Canada & Co. |
Eosinophil prostaglandin d2 receptor assays
|
|
US20040197834A1
(en)
|
2001-07-20 |
2004-10-07 |
Francois Gervais |
Method to increase expression of pgd2 receptors and assays for identifying modulators of prostaglandin d2 receptors
|
|
US20050101841A9
(en)
|
2001-12-04 |
2005-05-12 |
Kimberly-Clark Worldwide, Inc. |
Healthcare networks with biosensors
|
|
EP1540341A4
(en)
|
2002-07-01 |
2007-01-10 |
Univ Rochester Medical Ct |
METHOD FOR DETERMINING THE PROBABILITY OF PREPARING EASY WOMEN IN PREGNANT WOMEN
|
|
KR101215701B1
(ko)
|
2002-07-19 |
2012-12-26 |
베스 이스라엘 데코니스 메디칼 센터 |
자간전증 또는 자간의 진단 및 치료 방법
|
|
US7435419B2
(en)
|
2002-07-19 |
2008-10-14 |
Beth Israel Deaconess Medical Center |
Methods of diagnosing and treating pre-eclampsia or eclampsia
|
|
DK2204654T3
(da)
|
2002-08-13 |
2013-03-11 |
N Dia Inc |
Anordninger og fremgangsmåder til detektering af fostervand i vaginalsekretioner
|
|
EP1537420B1
(en)
|
2002-08-29 |
2010-10-06 |
Diagnostic Technologies Ltd. |
Method of diagnosis of pregnancy-related complications
|
|
JPWO2004030674A1
(ja)
|
2002-09-30 |
2006-01-26 |
塩野義製薬株式会社 |
プロスタグランジンｄ▲下２▼、プロスタグランジンｄ▲下２▼アゴニストおよびプロスタグランジンｄ▲下２▼アンタゴニストの新規用途
|
|
WO2004037206A2
(en)
|
2002-10-23 |
2004-05-06 |
University Of Hawaii |
Methods for diagnosing and treating pre-term labor
|
|
US20040100376A1
(en)
|
2002-11-26 |
2004-05-27 |
Kimberly-Clark Worldwide, Inc. |
Healthcare monitoring system
|
|
EP1590664A4
(en)
|
2003-02-05 |
2007-05-23 |
Ciphergen Biosystems Inc |
NON-INVASIVE ASSESSMENT OF THE INTRA-NAMINE ENVIRONMENT
|
|
ATE553378T1
(de)
|
2003-02-06 |
2012-04-15 |
Hologic Inc |
Screening und behandlungsverfahren zur vorbeugung von frühgeburten
|
|
US8068990B2
(en)
|
2003-03-25 |
2011-11-29 |
Hologic, Inc. |
Diagnosis of intra-uterine infection by proteomic analysis of cervical-vaginal fluids
|
|
US7191068B2
(en)
|
2003-03-25 |
2007-03-13 |
Proteogenix, Inc. |
Proteomic analysis of biological fluids
|
|
US20070003992A1
(en)
|
2003-04-09 |
2007-01-04 |
Pentyala Srinivas N |
Methods and kits for detecting cerebrospinal fluid in a sample
|
|
US8003765B2
(en)
|
2003-04-09 |
2011-08-23 |
Stony Brook Anaesthesiology, University Faculty Practice Corporation |
Methods, antibodies and kits for detecting cerebrospinal fluid in a sample
|
|
US20040203079A1
(en)
|
2003-04-09 |
2004-10-14 |
Research Foundation Of The State University Of New York |
Methods and kits for detecting cerebrospinal fluid in a sample
|
|
US8060195B2
(en)
|
2003-05-02 |
2011-11-15 |
The Johns Hopkins University |
Devices, systems and methods for bioimpedance measurement of cervical tissue and methods for diagnosis and treatment of human cervix
|
|
CA2526013A1
(en)
|
2003-05-20 |
2004-12-02 |
Merck Frosst Canada Ltd. |
Fluoro-methanesulfonyl-substituted cycloalkanoindoles and their use as prostaglandin d2 antagonists
|
|
WO2005007223A2
(en)
|
2003-07-16 |
2005-01-27 |
Sasha John |
Programmable medical drug delivery systems and methods for delivery of multiple fluids and concentrations
|
|
JP3897117B2
(ja)
|
2003-09-24 |
2007-03-22 |
マルハ株式会社 |
妊娠中毒症の重症度判定と予知方法、および妊娠中毒症における胎児・胎盤機能の評価方法
|
|
JP4354954B2
(ja)
|
2003-09-26 |
2009-10-28 |
株式会社マルハニチロ水産 |
関節リウマチの検出又は鑑別方法及び病期又は機能障害度の判別方法
|
|
US20050131287A1
(en)
|
2003-12-16 |
2005-06-16 |
Kimberly-Clark Worldwide, Inc. |
Detection of premature rupture of the amniotic membrane
|
|
AU2005280528B2
(en)
|
2004-07-30 |
2010-12-23 |
Adeza Biomedical Corporation |
Oncofetal fibronectin as a marker for disease and other conditions and methods for detection of oncofetal fibronectin
|
|
US20080090759A1
(en)
|
2004-08-30 |
2008-04-17 |
Robert Kokenyesi |
Methods and kits for predicting risk for preterm labor
|
|
US20080254479A1
(en)
|
2004-08-30 |
2008-10-16 |
Cervimark, Llc |
Methods and Kits For Predicting Risk For Preterm Labor
|
|
JP5270161B2
(ja)
|
2004-09-24 |
2013-08-21 |
ベス イスラエル デアコネス メディカル センター |
妊娠合併症を診断および処置する方法
|
|
GB0422057D0
(en)
|
2004-10-05 |
2004-11-03 |
Astrazeneca Ab |
Novel compounds
|
|
HN2005000795A
(es)
|
2004-10-15 |
2010-08-19 |
Aventis Pharma Inc |
Pirimidinas como antagonistas del receptor de prostaglandina d2
|
|
JP5009811B2
(ja)
|
2004-12-21 |
2012-08-22 |
イェール ユニバーシティ |
子癇前症の検出
|
|
CA2528531A1
(en)
|
2005-01-06 |
2006-07-06 |
Mount Sinai Hospital |
Markers of pre-term labor
|
|
DOP2006000016A
(es)
|
2005-01-26 |
2006-07-31 |
Aventis Pharma Inc |
2-fenil-indoles como antagonistas del receptor de la prostaglandina d2.
|
|
GB0505048D0
(en)
|
2005-03-11 |
2005-04-20 |
Oxagen Ltd |
Compounds with PGD antagonist activity
|
|
WO2006102498A2
(en)
*
|
2005-03-24 |
2006-09-28 |
Beth Israel Deaconess Medical Center |
Methods of diagnosing fetal trisomy 13 or a risk of fetal trisomy 13 during pregnancy
|
|
EP1910555A2
(en)
|
2005-07-13 |
2008-04-16 |
ECI Biotech Inc. |
Substrates, sensors, and methods for assessing conditions in females
|
|
JP5064219B2
(ja)
|
2005-07-22 |
2012-10-31 |
塩野義製薬株式会社 |
Ｐｇｄ２受容体アンタゴニスト活性を有するアザインドール酸誘導体
|
|
CN101309929A
(zh)
|
2005-09-15 |
2008-11-19 |
创源生物科技（武汉）有限公司 |
胎膜早破的一个标志物
|
|
GT200600457A
(es)
|
2005-10-13 |
2007-04-27 |
Aventis Pharma Inc |
Sal de fosfato dihidrogeno como antagonistas del receptor de prostaglandina d2
|
|
US8076315B2
(en)
|
2005-10-14 |
2011-12-13 |
The Board Of Trustees Of The University Of Illinois |
Pharmacological treatments for sleep disorders (apnoe) with prostanoid receptor antagonists
|
|
US20070111326A1
(en)
|
2005-11-14 |
2007-05-17 |
Abbott Laboratories |
Diagnostic method for proteinaceous binding pairs, cardiovascular conditions and preeclampsia
|
|
US20080009552A1
(en)
|
2006-03-23 |
2008-01-10 |
Craig Pennell |
Markers of pre-term labor
|
|
AR060403A1
(es)
|
2006-04-12 |
2008-06-11 |
Sanofi Aventis |
Compuestos de amino- pirimidina 2,6- sustituidos -4- monosustituidos como antagonistas del receptor de prostaglandina d2
|
|
DK2037967T3
(en)
|
2006-06-16 |
2017-03-13 |
Univ Pennsylvania |
PROSTAGLANDIN-D2 RECEPTOR ANTAGONISTS FOR TREATMENT OF ANDROGENETIC ALOPECI
|
|
EP2066628B1
(en)
|
2006-07-25 |
2010-10-20 |
Sanofi-Aventis |
2-phenyl-indoles as prostaglandin d2 receptor antagonists
|
|
WO2008039941A2
(en)
|
2006-09-27 |
2008-04-03 |
The Government Of The Usa As Represented By The Secretary Of The Dpt. Of Health And Human Services |
Scgb3a2 as a growth factor and anti-apoptotic agent
|
|
DK2918288T3
(da)
|
2006-10-03 |
2017-11-27 |
Genzyme Corp |
Anvendelse af TGF-beta-antagonister til behandling af spædbørn med risiko for udvikling af bronkopulmonal dysplasi
|
|
WO2008073491A1
(en)
|
2006-12-11 |
2008-06-19 |
University Of Florida Research Foundation, Inc. |
System and method for analyzing progress of labor and preterm labor
|
|
CA2672373C
(en)
|
2006-12-19 |
2011-08-30 |
Pfizer Products Inc. |
Nicotinamide derivatives as inhibitors of h-pgds and their use for treating prostaglandin d2 mediated diseases
|
|
KR20090115930A
(ko)
|
2006-12-26 |
2009-11-10 |
브라이엄 영 유니버시티 |
혈청 단백질체학 시스템 및 관련 방법
|
|
JP2010519328A
(ja)
|
2007-02-26 |
2010-06-03 |
ファイザー・プロダクツ・インク |
Ｈ−ｐｇｄｓの阻害剤としてのニコチンアミド誘導体およびプロスタグランジンｄ２が媒介する疾患の治療のためのそれらの使用
|
|
US20090058072A1
(en)
|
2007-08-30 |
2009-03-05 |
Shirlee Ann Weber |
Record sheets with integrated themes
|
|
US20100251394A1
(en)
|
2007-09-20 |
2010-09-30 |
The Johns Hopkins University |
Treatment and prevention of ischemic brain injury
|
|
WO2009059259A2
(en)
|
2007-10-31 |
2009-05-07 |
Children's Hospital Medical Center |
Detection of worsening renal disease in subjects with systemic lupus erythematosus
|
|
US20110002866A1
(en)
|
2007-10-31 |
2011-01-06 |
Lubit Beverly W |
Methods to prevent a hair-related side effect of treatment with a chemotherapeutic agent
|
|
US20100298368A1
(en)
|
2007-11-06 |
2010-11-25 |
Amira Pharmaceuticals, Inc. |
Antagonists of pgd2 receptors
|
|
US20130177485A1
(en)
|
2007-11-27 |
2013-07-11 |
Momtec Life Ltd. Of Yazmot Haemek |
Diagnostic device for identifying rupture of membrane during pregnancy
|
|
US20110065139A1
(en)
|
2007-11-27 |
2011-03-17 |
Jacob Mullerad |
diagnostic device for identifying rupture of membrane during pregnancy
|
|
DK2327693T3
(da)
|
2007-12-14 |
2012-08-13 |
Pulmagen Therapeutics Asthma Ltd |
Indoler og terapeutisk anvendelse deraf
|
|
EP2235529B1
(en)
|
2008-01-07 |
2016-12-14 |
Ortho-Clinical Diagnostics, Inc. |
Determination of sflt-1:angiogenic factor complex
|
|
WO2009090399A1
(en)
|
2008-01-18 |
2009-07-23 |
Argenta Discovery Limited |
Indoles active on crth2 receptor
|
|
US8647832B2
(en)
|
2008-01-25 |
2014-02-11 |
Perkinelmer Health Sciences, Inc. |
Methods for determining the risk of prenatal complications
|
|
US20100016173A1
(en)
|
2008-01-30 |
2010-01-21 |
Proteogenix, Inc. |
Maternal serum biomarkers for detection of pre-eclampsia
|
|
US20100017143A1
(en)
|
2008-01-30 |
2010-01-21 |
Proteogenix, Inc. |
Gestational age dependent proteomic changes of human maternal serum for monitoring maternal and fetal health
|
|
ES2566739T3
(es)
|
2008-02-01 |
2016-04-15 |
Brickell Biotech, Inc. |
Aminoalquilbifenilo N,N-disustituidos antagonistas de receptores de prostaglandina D2
|
|
EP2245002A4
(en)
|
2008-02-01 |
2011-08-17 |
Amira Pharmaceuticals Inc |
AMINOALKYLBIPHENYL ANTAGONISTS N, N 'DISUBSTITUTED FROM D2 RECEPTORS OF PROSTAGLANDIN
|
|
JP2011512359A
(ja)
|
2008-02-14 |
2011-04-21 |
アミラ ファーマシューティカルズ，インク． |
プロスタグランジンｄ２受容体のアンタゴニストとしての環式ジアリールエーテル化合物
|
|
WO2009108720A2
(en)
|
2008-02-25 |
2009-09-03 |
Amira Pharmaceuticals, Inc. |
Antagonists of prostaglandin d2 receptors
|
|
JP2011518130A
(ja)
|
2008-04-02 |
2011-06-23 |
アミラ ファーマシューティカルズ，インク． |
プロスタグランジンｄ２受容体のアミノアルキルフェニルアンタゴニスト
|
|
MX2010012448A
(es)
|
2008-05-16 |
2011-03-25 |
Corthera Inc Star |
Metodo para prevenir el parto prematuro.
|
|
US20110112134A1
(en)
|
2008-05-16 |
2011-05-12 |
Amira Pharmaceuticals, Inc. |
Tricyclic Antagonists of Prostaglandin D2 Receptors
|
|
JP2011526281A
(ja)
|
2008-06-24 |
2011-10-06 |
アミラ ファーマシューティカルズ，インク． |
プロスタグランジンｄ２受容体のシクロアルカン［ｂ］インドールアンタゴニスト
|
|
PE20100094A1
(es)
|
2008-07-03 |
2010-02-18 |
Amira Pharmaceuticals Inc |
Antagonistas heteroalquilo de receptores de prostaglandina d2
|
|
FR2934681B1
(fr)
|
2008-07-29 |
2011-09-30 |
Bastien Karkouche |
Dispositif pour la capture de particules biologiques et utilisation.
|
|
CA2735525A1
(en)
|
2008-08-04 |
2010-02-11 |
The Board Of Regents Of The University Of Texas System |
Multiplexed diagnostic test for preterm labor
|
|
US8536185B2
(en)
|
2008-09-22 |
2013-09-17 |
Cayman Chemical Company, Incorporated |
Multiheteroaryl compounds as inhibitors of H-PGDS and their use for treating prostaglandin D2 mediated diseases
|
|
GB2463788B
(en)
|
2008-09-29 |
2010-12-15 |
Amira Pharmaceuticals Inc |
Heteroaryl antagonists of prostaglandin D2 receptors
|
|
WO2010039977A2
(en)
|
2008-10-01 |
2010-04-08 |
Amira Pharmaceuticals, Inc. |
Heteroaryl antagonists of prostaglandin d2 receptors
|
|
US8524748B2
(en)
|
2008-10-08 |
2013-09-03 |
Panmira Pharmaceuticals, Llc |
Heteroalkyl biphenyl antagonists of prostaglandin D2 receptors
|
|
GB2465062B
(en)
|
2008-11-06 |
2011-04-13 |
Amira Pharmaceuticals Inc |
Cycloalkane(B)azaindole antagonists of prostaglandin D2 receptors
|
|
US8383654B2
(en)
|
2008-11-17 |
2013-02-26 |
Panmira Pharmaceuticals, Llc |
Heterocyclic antagonists of prostaglandin D2 receptors
|
|
US9180114B2
(en)
|
2008-11-26 |
2015-11-10 |
President And Fellows Of Harvard College |
Neurodegenerative diseases and methods of modeling
|
|
US20120004233A1
(en)
|
2009-01-26 |
2012-01-05 |
Amira Pharmaceuticals, Inc |
Tricyclic compounds as antagonists of prostaglandin d2 receptors
|
|
WO2010099211A2
(en)
|
2009-02-27 |
2010-09-02 |
University Of Utah Research Foundation |
Compositions and methods for diagnosing and preventing spontaneous preterm birth
|
|
GB0905964D0
(en)
|
2009-04-06 |
2009-05-20 |
King S College London |
Marker
|
|
CA2768587A1
(en)
|
2009-08-05 |
2011-02-10 |
Panmira Pharmaceuticals, Llc |
Dp2 antagonist and uses thereof
|
|
US20110090048A1
(en)
|
2009-09-29 |
2011-04-21 |
Li Conan K |
Data Transmission Device with User Identification Capability
|
|
US20120270747A1
(en)
|
2009-10-29 |
2012-10-25 |
The Trustees Of The University Of Pennsylvania |
Method of predicting risk of pre-term birth
|
|
CA2778838A1
(en)
|
2009-11-12 |
2011-05-19 |
Cervilenz Inc. |
Devices and methods for cervix measurement
|
|
US8663576B2
(en)
|
2009-11-25 |
2014-03-04 |
Hologic, Inc. |
Detection of intraamniotic infection
|
|
EP2510356B1
(en)
|
2009-12-08 |
2018-10-31 |
Cedars-Sinai Medical Center |
Diagnostic method to identify women at risk for preterm delivery
|
|
US8874183B2
(en)
|
2010-02-18 |
2014-10-28 |
The Johns Hopkins University |
Preterm labor monitor
|
|
TW201204708A
(en)
|
2010-03-16 |
2012-02-01 |
Aventis Pharma Inc |
A substituted pyrimidine as a prostaglandin D2 receptor antagonist
|
|
EP2547672A1
(en)
|
2010-03-16 |
2013-01-23 |
Aventis Pharmaceuticals Inc. |
Substituted pyrimidines as prostaglandin d2 receptor antagonists
|
|
MX2012010820A
(es)
|
2010-03-22 |
2012-10-10 |
Actelion Pharmaceuticals Ltd |
Derivados de 3-(heteroaril-amino)-1, 2, 3, 4-tetrahidro-9h-carbazo l y sus uso como moduladores del receptor de prostaglandina d2.
|
|
WO2011119757A2
(en)
|
2010-03-23 |
2011-09-29 |
The Reproductive Research Technologies, Lp |
Noninvasive measurement of uterine emg propagation and power spectrum frequency to predict true preterm labor and delivery
|
|
JP2013524251A
(ja)
*
|
2010-04-13 |
2013-06-17 |
プロノタ エヌ．ヴェ． |
妊娠高血圧疾患のバイオマーカー
|
|
EP3248946B1
(en)
*
|
2010-05-14 |
2021-02-24 |
Beth Israel Deaconess Medical Center, Inc. |
Extracorporeal devices and methods of treating complications of pregnancy
|
|
US20110312928A1
(en)
|
2010-06-18 |
2011-12-22 |
Lipocine Inc. |
Progesterone Containing Oral Dosage Forms and Related Methods
|
|
US20110312927A1
(en)
|
2010-06-18 |
2011-12-22 |
Satish Kumar Nachaegari |
Progesterone Containing Oral Dosage Forms and Related Methods
|
|
WO2011163554A2
(en)
|
2010-06-25 |
2011-12-29 |
Winthrop-University Hospital |
Lipocalin-type prostaglandin d2 synthase as a biomarker for lung cancer progression and prognosis
|
|
EP2590944B1
(en)
|
2010-07-05 |
2015-09-30 |
Actelion Pharmaceuticals Ltd. |
1-phenyl-substituted heterocyclyl derivatives and their use as prostaglandin d2 receptor modulators
|
|
CN103249348B
(zh)
|
2010-07-12 |
2017-07-18 |
瑟拉赛恩传感器股份有限公司 |
用于个体的体内监视的设备和方法
|
|
US8765487B2
(en)
|
2010-09-01 |
2014-07-01 |
Clinical Innovations |
Detection of amniotic fluid in vaginal secretions of pregnant women due to premature rupture of fetal membranes
|
|
JP6012052B2
(ja)
|
2010-10-01 |
2016-10-25 |
ホロジック, インコーポレイテッドHologic, Inc. |
診断システムに使用する免疫検定検査ストリップ
|
|
US10669569B2
(en)
|
2010-10-15 |
2020-06-02 |
Navinci Diagnostics Ab |
Dynamic range methods
|
|
CN103415769B
(zh)
|
2010-12-06 |
2017-04-12 |
迈卡蒂斯股份有限公司 |
用于妊娠性高血压疾病的生物标志物和参数
|
|
GB201101621D0
(en)
|
2011-01-31 |
2011-03-16 |
Olink Ab |
Method and product
|
|
US20120196285A1
(en)
|
2011-01-31 |
2012-08-02 |
Esoterix Genetic Laboratories, Llc |
Methods for Enriching Microparticles or Nucleic Acids Using Binding Molecules
|
|
US8951996B2
(en)
|
2011-07-28 |
2015-02-10 |
Lipocine Inc. |
17-hydroxyprogesterone ester-containing oral compositions and related methods
|
|
CA2850449C
(en)
*
|
2011-11-09 |
2021-06-01 |
F. Hoffmann-La Roche Ag |
Dynamic of sflt-1 or endoglin/pigf ratio as an indicator for imminent preeclampsia and/or hellp syndrome
|
|
EP2812698B1
(en)
|
2012-02-06 |
2020-10-28 |
PerkinElmer Health Sciences Canada, Inc. |
Dual-acceptor time-resolved-fret
|
|
JP2015519564A
(ja)
|
2012-05-08 |
2015-07-09 |
ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティ |
子癇前症評価を提供するための方法および組成物
|
|
CN104412107B
(zh)
|
2012-06-27 |
2018-06-08 |
弗·哈夫曼-拉罗切有限公司 |
用sFlt-1/PlGF或内皮糖蛋白/PlGF比值来排除先兆子痫在某时期内发病的手段和方法
|
|
EP2890816B1
(en)
|
2012-08-30 |
2019-06-05 |
Ansh Labs LLC |
Papp-a2 as a marker for monitoring, predicting and diagnosing preeclampsia
|
|
EP2912458B1
(en)
|
2012-10-24 |
2018-07-18 |
NYU Winthrop Hospital |
Non-invasive biomarker to identify subjects at risk of preterm delivery
|
|
US20150330989A1
(en)
*
|
2012-11-15 |
2015-11-19 |
The Brigham And Women's Hospital, Inc. |
Method and system for diagnosing and treating preeclampsia
|
|
US20160025738A1
(en)
*
|
2013-03-04 |
2016-01-28 |
Iq Products B.V. |
Prognostic marker to determine the risk for early-onset preeclampsia
|
|
CN105917232B
(zh)
|
2013-12-03 |
2020-10-16 |
塞尚公司 |
用于选择性确定胎盘生长因子2的方法
|
|
EP3097422B1
(en)
|
2014-01-24 |
2018-07-11 |
Roche Diagnostics GmbH |
Prediction of postpartum hellp syndrome, postpartum eclampsia or postpartum preeclampsia
|
|
US10281475B2
(en)
|
2014-03-27 |
2019-05-07 |
Wayne State University |
Systems and methods to identify and treat subjects at risk for obstetrical complications
|
|
WO2016019176A1
(en)
|
2014-07-30 |
2016-02-04 |
Matthew Cooper |
Methods and compositions for diagnosing, prognosing, and confirming preeclampsia
|
|
EP3259600B1
(en)
|
2015-02-18 |
2024-07-24 |
MirZyme Therapeutics Limited |
Diagnostic assay and treatment for preeclampsia
|
|
WO2016134324A1
(en)
|
2015-02-20 |
2016-08-25 |
Neoteryx, Llc |
Method and apparatus for acquiring blood for testing
|
|
WO2016149759A1
(en)
|
2015-03-23 |
2016-09-29 |
Adelaide Research & Innovation Pty Ltd |
Methods and systems for determining risk of a pregnancy complication occurring
|
|
AU2016319010A1
(en)
|
2015-09-11 |
2018-04-12 |
Universidad De Los Andes |
In vitro method for identifying a pregnancy related issue
|
|
NL2016967B1
(en)
|
2016-06-15 |
2017-12-21 |
Iq Products B V |
Markers and their ratio to determine the risk for early-onset preeclampsia.
|
|
WO2018145119A1
(en)
|
2017-02-06 |
2018-08-09 |
Astute Medical, Inc. |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
|
US20190079097A1
(en)
|
2017-09-13 |
2019-03-14 |
Progenity, Inc. |
Preeclampsia biomarkers and related systems and methods
|
|
US20200264188A1
(en)
|
2017-09-13 |
2020-08-20 |
Progenity, Inc. |
Preeclampsia biomarkers and related systems and methods
|